Search

Teva Pharmaceutical Industries Ltd.

Gesloten

SectorGezondheidszorg

34.79 0.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

34.26

Max

34.86

Belangrijke statistieken

By Trading Economics

Inkomsten

-944M

-575M

Verkoop

161M

4.1B

K/W

Sectorgemiddelde

57.433

68.51

EPS

0.64

Winstmarge

-13.882

Werknemers

31,173

EBITDA

-478M

399M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+18.58% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

4B

40B

Vorige openingsprijs

34.59

Vorige sluitingsprijs

34.79

Nieuwssentiment

By Acuity

3%

97%

2 / 340 Rangschikking in Healthcare

Teva Pharmaceutical Industries Ltd. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 aug 2026, 23:56 UTC

News

CACI International reported Q2 sales of $2.71 billion, exceeding expectations. Shares advanced in after-market trading following strong earnings and optimistic full-year guidance.

5 aug 2026, 23:56 UTC

Correlated Moves
News
Social Media

Magnolia Oil & Gas reported net income of $181.8 million and adjusted EPS of $0.99, exceeding estimates, contributing to after-market gains.

5 aug 2026, 23:56 UTC

Correlated Moves
News

Entergy Corp shares rose in after-market trading, supported by a $35 million contract awarded to ICF for energy efficiency programs.

5 aug 2026, 23:56 UTC

Correlated Moves
News

Uranium Energy Corp gains in after-market trading, influenced by Cameco's rise amid cautious market sentiment following a weak ADP employment report.

5 aug 2026, 23:51 UTC

News

Global Net Lease raised its 2026 FFO guidance to $0.82-$0.85, aligning with estimates, contributing to after-market gains following its earnings report.

5 aug 2026, 23:51 UTC

Social Media
News

UWM Holdings Corp shares are lower after announcing a $400 million rights offering and suspending its common dividend to focus on debt reduction.

5 aug 2026, 23:51 UTC

News

Forward Air Corp reported record Q2 revenue of $673 million. Analysts reacted positively, contributing to a sharp rise in shares during after-market trading.

5 aug 2026, 23:51 UTC

News
Social Media

American Superconductor Corp shares fell in after-market hours following first-quarter earnings that missed expectations and disappointing second-quarter guidance.

5 aug 2026, 23:51 UTC

News

Akebia Therapeutics shares fell in after-market trading following a second-quarter net loss of $8.9 million and declining revenue amid increased competition.

5 aug 2026, 23:51 UTC

News

Cooper-Standard Holdings reported a net loss of $18.8 million and an adjusted EPS of -$0.13, contributing to a decline in after-market hours.

5 aug 2026, 23:51 UTC

News

Goodyear Tire & Rubber Co. shares are trading higher in after-market hours following a second-quarter adjusted EPS loss of $0.61, better than expected.

5 aug 2026, 23:51 UTC

News
Social Media

Axon Enterprise reported Q2 revenue of $904 million but saw net income drop to $29 million. Shares fell significantly in after-hours trading.

5 aug 2026, 23:51 UTC

News

IDEXX Laboratories shares rise in after-hours trading as UBS raises price target to $670 while maintaining a Neutral rating.

5 aug 2026, 23:51 UTC

Social Media
News

eBay Inc reported second-quarter adjusted EPS of $1.60, surpassing estimates. Shares rose in after-market hours as revenue also exceeded expectations.

5 aug 2026, 23:51 UTC

News
Social Media

HubSpot shares are lower in after-hours trading despite Q2 revenue of $911.7 million and adjusted EPS of $3.26, amid a cautious Q3 outlook.

5 aug 2026, 23:51 UTC

Social Media
News

Expedia Group reported strong second-quarter results, with adjusted EPS of $5.76 and revenues of $4.32 billion. Shares are trading lower in after-market hours.

5 aug 2026, 23:51 UTC

News

Coeur Mining shares fell in after-market trading following second-quarter earnings of $0.12 per share, missing the consensus estimate of $0.32.

5 aug 2026, 23:46 UTC

Correlated Moves
News
Social Media

Matador Resources reported Q2 sales of $1.19 billion and a non-GAAP profit of $2.61 per share. Shares rose in after-market trading following the results.

5 aug 2026, 23:46 UTC

News

Rivian Automotive has secured a $1.25 billion partnership with Uber. Shares are lower in after-market trading amid cautious sentiment from weak U.S. employment data.

5 aug 2026, 23:46 UTC

News

Ohio directs AEP to protect customers from data center impacts.

5 aug 2026, 23:46 UTC

News

Western Union launches Stablecard, a digital wallet utilizing USDPT. Shares are lower in after-market trading, continuing a narrow performance range since Wednesday's close.

5 aug 2026, 23:46 UTC

Social Media
News

NVIDIA Corp shares advanced in after-market hours following a $3.4 billion cloud services agreement with Iren and renewed analyst confidence in the stock.

5 aug 2026, 23:42 UTC

News

Eli Lilly reported second-quarter revenue of $23 billion, raising its full-year guidance to $85 billion to $87 billion. Shares are higher in after-market trading.

5 aug 2026, 23:41 UTC

News

Victory Capital Holdings reported strong Q2 results, with adjusted EPS of $2.21 and sales of $435.4 million, driving shares higher in after-market hours.

5 aug 2026, 23:41 UTC

News

Qualys Inc reported second-quarter revenue of nearly $182.2 million, surpassing expectations, and shares are higher in after-market trading.

5 aug 2026, 23:41 UTC

News

Toast Inc shares are lower in after-market hours following a downgrade to neutral, reflecting concerns over valuation amid macroeconomic challenges and competition.

5 aug 2026, 23:41 UTC

News

Lumen Technologies shares are higher in after-market hours following a partnership with Amdocs to enhance enterprise service orchestration using AI-driven capabilities.

5 aug 2026, 23:41 UTC

News
Social Media

Vir Biotechnology reported second-quarter revenue of $238.9 million, exceeding estimates, contributing to significant gains in after-market trading.

5 aug 2026, 23:41 UTC

News
Social Media

NN Inc reported strong Q2 results, raising full-year sales guidance to $460 million to $470 million. Shares are trading sharply higher in after-market hours.

5 aug 2026, 23:41 UTC

Social Media
News

Dutch Bros Inc. shares declined after strong Q2 results and guidance, amid investor concerns over the planned acquisition of Salad and Go locations.

Peer Vergelijking

Prijswijziging

Teva Pharmaceutical Industries Ltd. Prognose

Koersdoel

By TipRanks

18.58% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 41.17 USD  18.58%

Hoogste 44 USD

Laagste 40 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Teva Pharmaceutical Industries Ltd. - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Sentiment

By Acuity

2 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
help-icon Live chat